These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16122787)

  • 1. Angiotensin II augmented migration and invasion of choriocarcinoma cells involves PI3K activation through the AT1 receptor.
    Ishimatsu S; Itakura A; Okada M; Kotani T; Iwase A; Kajiyama H; Ino K; Kikkawa F
    Placenta; 2006; 27(6-7):587-91. PubMed ID: 16122787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway.
    Ino K; Uehara C; Kikkawa F; Kajiyama H; Shibata K; Suzuki T; Khin EE; Ito M; Takeuchi M; Itakura A; Mizutani S
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3973-82. PubMed ID: 12915695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
    Liu HW; Cheng B; Yu WL; Sun RX; Zeng D; Wang J; Liao YX; Fu XB
    Life Sci; 2006 Jun; 79(5):475-83. PubMed ID: 16522324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
    Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L
    J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II induces proliferation of cultured rat astrocytes through c-Jun N-terminal kinase.
    Clark MA; Guillaume G; Pierre-Louis HC
    Brain Res Bull; 2008 Jan; 75(1):101-6. PubMed ID: 18158102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor.
    Tone A; Shikata K; Ogawa D; Sasaki S; Nagase R; Sasaki M; Yozai K; Usui HK; Okada S; Wada J; Shikata Y; Makino H
    J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):45-50. PubMed ID: 17487826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats.
    Li L; Zhu DL; Shen WL; Gao PJ
    Hypertens Res; 2006 Feb; 29(2):95-103. PubMed ID: 16755143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation.
    Takeuchi Y; Yamauchi K; Nakamura J; Shigematsu S; Hashizume K
    J Endocrinol; 2006 Nov; 191(2):361-7. PubMed ID: 17088405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
    Kamińska M; Mogielnicki A; Stankiewicz A; Kramkowski K; Domaniewski T; Buczko W; Chabielska E
    J Physiol Pharmacol; 2005 Dec; 56(4):571-85. PubMed ID: 16391415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
    Kou B; Vatish M; Singer DR
    Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and retinal pericytes migration.
    Nadal JA; Scicli GM; Carbini LA; Nussbaum JJ; Scicli AG
    Biochem Biophys Res Commun; 1999 Dec; 266(2):382-5. PubMed ID: 10600512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
    Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
    J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell.
    Imanishi T; Kobayashi K; Kuroi A; Ikejima H; Akasaka T
    Hypertens Res; 2008 Apr; 31(4):757-65. PubMed ID: 18633188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.